CRH Medical renews normal course issuer bid — 3 insights

The Toronto Stock Exchange approved CRH Medical’s intention to renew its normal course issuer bid.

Advertisement

Here’s what you should know:

1. CRH may purchase up to 7 million of its common shares, representing 9.74 percent of its outstanding common shares.

2. CRH currently has 72.3 million in common shares and a public float of 70.44 million.

3. CRH will fund the bid with generated cash flow.

More articles on healthcare: 
3 thoughts on managing denials from employer plans
GI societies slam CMS decision to side with Anthem, devalue GI codes — 5 insights
USPI delivers $502M operating revenue in Q3, Tenet’s hospital operations disappoint

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.